(4 Dec 2023) Knowledge services provider Taylor & Francis has today announced the addition of Future Science Group (FSG), publisher of medical, biotechnological and scientific research. As well as bringing a portfolio of cutting-edge journals and digital hubs, FSG’s leading publishing solutions program will enable Taylor & Francis to offer researchers and medical communication planners a host of additional services.
Taylor & Francis now becomes the fourth largest publisher of pharma-funded research, with the addition of 32 peer-reviewed FSG journals and five digital hubs. These complement the existing range of over 340 Taylor & Francis medical and healthcare journals, including the Expert Collection, which is the world’s largest series of review journals in research, development and clinical medicine.
FSG publications represent many of the most important and fast-growing fields of scientific, medical and pharmaceutical research, including oncology, medicinal chemistry, immunotherapy, microbiology, nanomedicine and biotechnology. Researchers can choose to publish open access (OA) in all FSG journals, with 15 titles fully OA.
The addition of FSG will also accelerate the growth of Taylor & Francis services for researchers and medical communication planners. FSG’s market-leading Plain Language Summary Hub supports authors to make technical content accessible for lay audiences and empowers patients in decision-making about their care.
The press release in full is here.
